Zum Inhalt springen

IP Blogs

CRISPR’s broad adoption requires flexible approach to licensing, says ERS Genomics patent boss 
ERS IP head Michael Arciero tells IAM how his company is seeking to overcome licensing challenges in a complex and growing market
Thu, 15 Oct 2026 07:00:00 +0200
Pictiva and Samsung settle OLED dispute following $191 million verdict, Squires intervention
The Key Patent Innovations entity won a massive jury verdict but then lost a patent invalidity challenge before the USPTO director weighed in
Wed, 14 Oct 2026 14:00:00 +0200
Amazon, Google and Microsoft back nationwide litigation funding disclosure rule
More than 200 companies support uniform federal requirements, while inventor advocates warn broad di ...
Wed, 14 Oct 2026 12:00:46 +0200
Why “patent pending” has stopped impressing investors and what start-ups must do instead
Investors are focusing less on whether an application is pending and more on the quality of the unde ...
Wed, 14 Oct 2026 10:20:00 +0200
AI is coming for your claim charts
The latest Richardson Oliver annual Patent Market Report finds more but smaller offerings and fallin ...
Wed, 14 Oct 2026 07:00:00 +0200
Supplier secrets and in-house R&D collide in $116.9m eVTOL aircraft verdict
A jury verdict in Aerosonic v Joby shows why supplier contracts, technical records and development t ...
Tue, 13 Oct 2026 14:26:01 +0200
Merck suffers eight-country Keytruda SC sales ban in latest European cross-border injunction
Dutch court decision is a reminder that multi-country injunctions available outside the UPC
Tue, 13 Oct 2026 14:08:35 +0200
AI innovation and PTAB shifts rewrite the patent litigation playbook for US companies
New survey data shows businesses taking a more selective approach to PTAB challenges while in-house ...
Tue, 13 Oct 2026 13:00:00 +0200